The latest closing stock price for Oncternal Therapeutics as of September 18, 2024 is 1.65.
An investor who bought $1,000 worth of Oncternal Therapeutics stock at the IPO in 2004 would have $-1,000 today, roughly -1 times their original investment - a -35.78% compound annual growth rate over 21 years.
The all-time high Oncternal Therapeutics stock closing price was 32731.86 on April 25, 2007.
The Oncternal Therapeutics 52-week high stock price is 13.14, which is 696.4% above the current share price.
The Oncternal Therapeutics 52-week low stock price is 1.32, which is 20% below the current share price.
The average Oncternal Therapeutics stock price for the last 52 weeks is 7.50.
An investor who bought $1,000 worth of Oncternal Therapeutics stock at the IPO in 2004 would have $-1,000 today, roughly -1 times their original investment - a -35.78% compound annual growth rate over 21 years.
The all-time high Oncternal Therapeutics stock closing price was 32731.86 on April 25, 2007.
The Oncternal Therapeutics 52-week high stock price is 13.14, which is 696.4% above the current share price.
The Oncternal Therapeutics 52-week low stock price is 1.32, which is 20% below the current share price.
The average Oncternal Therapeutics stock price for the last 52 weeks is 7.50.